Can ophthalmologists achieve better blood glucose control in their diabetic patients?

JAMA Ophthalmology

Volumn 133, Issue 8, 2015, Pages 897-898

  Frank, Robert N ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIET; DISEASE COURSE; EXERCISE; EYE EXAMINATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH INSURANCE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OPHTHALMOLOGIST; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; AMBULATORY CARE; ANALYSIS; FEMALE; MALE; OPHTHALMOLOGY;

BLOOD GLUCOSE; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; OFFICE VISITS; OPHTHALMOLOGY;

EID: 84939487443     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2015.2258     Document Type: Note

References (7)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14): 977-986.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853.
3. Aiello LP, Ayala AR, Antoszyk AN, et al; Diabetic Retinopathy Clinical Research Network. Assessing the effect of personalized diabetes risk assessments during ophthalmologic visits on glycemic control: a randomized clinical trial [published onlineMay 21, 2015]. JAMA Ophthalmol. doi:10.1001/jamaophthalmol.2015.1312.
4. Do DV, Nguyen QD, Bressler NM, et al. Hemoglobin A1c awareness among patients receiving eye care at a tertiary ophthalmic center. Am J Ophthalmol. 2006;141(5):951-953.
5. White NH, Sun W, Cleary PA, et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol. 2008;126(12):1707-1715.
6. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359 (15):1577-1589.
7. Gawande A. Overkill. New Yorker. May 11, 2015.